(Reuters) – Inovio Pharmaceuticals Inc said on Thursday it received authorization from Brazil’s regulatory agency to conduct mid-to-late stage trial of its COVID-19 vaccine.
(Reporting by Mrinalika Roy in Bengaluru)
Inovio to start COVID-19 vaccine trial after getting Brazil regulator approval
Aug 26, 2021 | 7:17 AM
